Clinical Trial Update: Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease [Phase 2]

View source ↗

Summary

Sponsored by Dr. Falk Pharma GmbH, a Phase 2 trial comparing Trichuris suis ova (TSO) suspension to placebo in active Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Trichuris suis ova (TSO) Suspension (Trichuris suis ova suspension)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Crohn´s Disease | Phase 2 | Status: COMPLETED